# FDA Inspection 1116511 - Biogenesis, Inc - January 17, 2020

Source: https://www.globalkeysolutions.net/records/fda_inspections/biogenesis-inc/2c0d6a9b-d61d-4cdb-95f0-7cd9432f9b5c
Source feed: FDA_Inspections

> FDA Inspection 1116511 for Biogenesis, Inc on January 17, 2020. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1116511
- Company Name: Biogenesis, Inc
- Inspection Date: 2020-01-17
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1260213 - 2025-02-27](https://www.globalkeysolutions.net/records/fda_inspections/biogenesis-inc/a36a341e-ba5d-4181-ba30-4c5bdc6f36e0)
- [FDA Inspection 904579 - 2014-11-18](https://www.globalkeysolutions.net/records/fda_inspections/biogenesis-inc/4ea78634-c3a1-4665-b55b-06382f2dd5ef)
- [FDA Inspection 765724 - 2012-02-02](https://www.globalkeysolutions.net/records/fda_inspections/biogenesis-inc/c82679bc-9830-46f6-b746-73a00a24f859)
- [FDA Inspection 669967 - 2010-08-05](https://www.globalkeysolutions.net/records/fda_inspections/biogenesis-inc/5dfadb4b-8746-45e0-90a5-615f3e532aba)

Company: https://www.globalkeysolutions.net/companies/biogenesis-inc/847a28b3-ca74-493b-a09f-eedbdfa0c5fc

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c